M Liu1, S M Malone2, U Vaidyanathan3, M C Keller1, G Abecasis4, M McGue2, W G Iacono2, S I Vrieze1. 1. Institute for Behavioral Genetics, University of Colorado Boulder,Boulder, CO,USA. 2. Department of Psychology,University of Minnesota,Minneapolis, MN,USA. 3. National Institutes of Health,Bethesda, MD,USA. 4. Department of Biostatistics,University of Michigan,Ann Arbor, MI,USA.
Abstract
BACKGROUND: Endophenotypes are laboratory-based measures hypothesized to lie in the causal chain between genes and clinical disorder, and to serve as a more powerful way to identify genes associated with the disorder. One promise of endophenotypes is that they may assist in elucidating the neurobehavioral mechanisms by which an associated genetic polymorphism affects disorder risk in complex traits. We evaluated this promise by testing the extent to which variants discovered to be associated with schizophrenia through large-scale meta-analysis show associations with psychophysiological endophenotypes. METHOD: We genome-wide genotyped and imputed 4905 individuals. Of these, 1837 were whole-genome-sequenced at 11× depth. In a community-based sample, we conducted targeted tests of variants within schizophrenia-associated loci, as well as genome-wide polygenic tests of association, with 17 psychophysiological endophenotypes including acoustic startle response and affective startle modulation, antisaccade, multiple frequencies of resting electroencephalogram (EEG), electrodermal activity and P300 event-related potential. RESULTS: Using single variant tests and gene-based tests we found suggestive evidence for an association between contactin 4 (CNTN4) and antisaccade and P300. We were unable to find any other variant or gene within the 108 schizophrenia loci significantly associated with any of our 17 endophenotypes. Polygenic risk scores indexing genetic vulnerability to schizophrenia were not related to any of the psychophysiological endophenotypes after correction for multiple testing. CONCLUSIONS: The results indicate significant difficulty in using psychophysiological endophenotypes to characterize the genetically influenced neurobehavioral mechanisms by which risk loci identified in genome-wide association studies affect disorder risk.
BACKGROUND: Endophenotypes are laboratory-based measures hypothesized to lie in the causal chain between genes and clinical disorder, and to serve as a more powerful way to identify genes associated with the disorder. One promise of endophenotypes is that they may assist in elucidating the neurobehavioral mechanisms by which an associated genetic polymorphism affects disorder risk in complex traits. We evaluated this promise by testing the extent to which variants discovered to be associated with schizophrenia through large-scale meta-analysis show associations with psychophysiological endophenotypes. METHOD: We genome-wide genotyped and imputed 4905 individuals. Of these, 1837 were whole-genome-sequenced at 11× depth. In a community-based sample, we conducted targeted tests of variants within schizophrenia-associated loci, as well as genome-wide polygenic tests of association, with 17 psychophysiological endophenotypes including acoustic startle response and affective startle modulation, antisaccade, multiple frequencies of resting electroencephalogram (EEG), electrodermal activity and P300 event-related potential. RESULTS: Using single variant tests and gene-based tests we found suggestive evidence for an association between contactin 4 (CNTN4) and antisaccade and P300. We were unable to find any other variant or gene within the 108 schizophrenia loci significantly associated with any of our 17 endophenotypes. Polygenic risk scores indexing genetic vulnerability to schizophrenia were not related to any of the psychophysiological endophenotypes after correction for multiple testing. CONCLUSIONS: The results indicate significant difficulty in using psychophysiological endophenotypes to characterize the genetically influenced neurobehavioral mechanisms by which risk loci identified in genome-wide association studies affect disorder risk.
Entities:
Keywords:
Endophenotypes; gene-based tests; polygenic risk scores; schizophrenia; single variant association
Authors: Alkes L Price; Gregory V Kryukov; Paul I W de Bakker; Shaun M Purcell; Jeff Staples; Lee-Jen Wei; Shamil R Sunyaev Journal: Am J Hum Genet Date: 2010-05-13 Impact factor: 11.025
Authors: Stephen M Malone; Scott J Burwell; Uma Vaidyanathan; Michael B Miller; Matt McGue; William G Iacono Journal: Psychophysiology Date: 2014-12 Impact factor: 4.016
Authors: Scott I Vrieze; Stephen M Malone; Nathan Pankratz; Uma Vaidyanathan; Michael B Miller; Hyun Min Kang; Matt McGue; Gonçalo Abecasis; William G Iacono Journal: Psychophysiology Date: 2014-12 Impact factor: 4.016
Authors: Scott I Vrieze; Shuang Feng; Michael B Miller; Brian M Hicks; Nathan Pankratz; Gonçalo R Abecasis; William G Iacono; Matt McGue Journal: Biol Psychiatry Date: 2013-10-04 Impact factor: 13.382
Authors: Sayantan Das; Lukas Forer; Sebastian Schönherr; Carlo Sidore; Adam E Locke; Alan Kwong; Scott I Vrieze; Emily Y Chew; Shawn Levy; Matt McGue; David Schlessinger; Dwight Stambolian; Po-Ru Loh; William G Iacono; Anand Swaroop; Laura J Scott; Francesco Cucca; Florian Kronenberg; Michael Boehnke; Gonçalo R Abecasis; Christian Fuchsberger Journal: Nat Genet Date: 2016-08-29 Impact factor: 38.330
Authors: J L Meyers; D B Chorlian; T B Bigdeli; E C Johnson; F Aliev; A Agrawal; L Almasy; A Anokhin; H J Edenberg; T Foroud; A Goate; C Kamarajan; S Kinreich; J Nurnberger; A K Pandey; G Pandey; M H Plawecki; J E Salvatore; J Zhang; A Fanous; B Porjesz Journal: Transl Psychiatry Date: 2021-01-14 Impact factor: 6.222
Authors: Jeremy Harper; Mengzhen Liu; Stephen M Malone; Matt McGue; William G Iacono; Scott I Vrieze Journal: Psychol Med Date: 2021-03-18 Impact factor: 10.592
Authors: Siri Ranlund; Stella Calafato; Johan H Thygesen; Kuang Lin; Wiepke Cahn; Benedicto Crespo-Facorro; Sonja M C de Zwarte; Álvaro Díez; Marta Di Forti; Conrad Iyegbe; Assen Jablensky; Rebecca Jones; Mei-Hua Hall; Rene Kahn; Luba Kalaydjieva; Eugenia Kravariti; Colm McDonald; Andrew M McIntosh; Andrew McQuillin; Marco Picchioni; Diana P Prata; Dan Rujescu; Katja Schulze; Madiha Shaikh; Timothea Toulopoulou; Neeltje van Haren; Jim van Os; Evangelos Vassos; Muriel Walshe; Cathryn Lewis; Robin M Murray; John Powell; Elvira Bramon Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2017-08-29 Impact factor: 3.568
Authors: William G Iacono; Andrew C Heath; John K Hewitt; Michael C Neale; Marie T Banich; Monica M Luciana; Pamela A Madden; Deanna M Barch; James M Bjork Journal: Dev Cogn Neurosci Date: 2017-09-12 Impact factor: 6.464
Authors: Yu Jiang; Sai Chen; Daniel McGuire; Fang Chen; Mengzhen Liu; William G Iacono; John K Hewitt; John E Hokanson; Kenneth Krauter; Markku Laakso; Kevin W Li; Sharon M Lutz; Matthew McGue; Anita Pandit; Gregory J M Zajac; Michael Boehnke; Goncalo R Abecasis; Scott I Vrieze; Xiaowei Zhan; Bibo Jiang; Dajiang J Liu Journal: PLoS Genet Date: 2018-07-17 Impact factor: 5.917